Diagnostic Routes and Time Intervals for Ovarian Cancer in Nine International Jurisdictions; Findings From the International Cancer Benchmarking Partnership (ICBP). Issue 12 (December 2022)

• Record Type: Journal Article
• Authors: Menon, Usha; Weller, David; Falborg, Alina Zalounina; Jensen, Henry; Butler, John; Barisic, Andriana; Knudsen, Anne Kari; Bergin, Rebecca J.; Brewster, David H.; Cairnduff, Victoria; Fourkala, Evangelia Ourania; Gavin, Anna T.; Grunfeld, Eva; Harland, Elizabeth; Kalsi, Jatinderpal; Law, Rebecca-Jane; Lin, Yulan; Turner, Donna; Neal, Richard D.; White, Victoria; Harrison, Samantha; Reguilon, Irene; Lynch, Charlotte; Vedsted, Peter
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 12(2022)
• Page Start: 739
• Page End: 740
• Publication Date: 2022-12
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000905360.00777.66
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Br J Cancer 2022;127:844–854) Ovarian cancer (OC) is the gynecological malignancy with the highest mortality, partially attributable to the lack of effective screening for early-stage disease. Despite inadequate screening methods, there exists significant international variation in the proportion diagnosed at late stage and in OC survival across all stages.